insights_auto
Why is ARX down 2.97%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.49
arrow_downward
-2.97%(-0.015) 1D
Nov 19, 4:10:03 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.49
High
A$0.51
Low
A$0.49
Mkt. cap
163.68M
Avg. vol.
259.34K
Volume
245.68K
P/E ratio
46.67
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.49
High
A$0.51
Low
A$0.49
Mkt. cap
163.68M
Avg. vol.
259.34K
Volume
245.68K
P/E ratio
46.67
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Barron's
·
51 minutes ago
Sell the S&P 500 Because the AI Bubble Is About to Burst, Analyst Says. Buy This Instead.
BigGo Finance
·
2 hours ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
TradingView
·
2 hours ago
Stock Market Today: Dow, S&P 500 Futures Rise as Wall Street Awaits Anthropic's Listing— PANW, NTES, SLS in Focus
JournalArta
·
45 minutes ago
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd